Irregular heartbeat The most common indications for<unk>  are atrial fibrillation and atrial flutter with rapid ventricular response, though beta blockers and/or calcium channel blockers may be preferred in some patients, such as those without heart failure or hemodynamic instability. One 2015 review found that<unk>  increases the risk of death, while another reported no change in mortality. It has been suggested that the effect on mortality seen in some studies was due to inappropriately high doses of<unk>  and that the low doses often used in practice (levels <0.9 ng/ml) may not increase mortality. Cardiac arrythmias may also occur when patients are prescribed<unk>  alongside thiazides and loop diuretics. Heart failure<unk>  is no longer the first choice for heart failure; it has fallen out of favor in people with heart failure because it may increase the risk of death. Currently, the recommendation for heart failure is a triple therapy of ACE inhibitor, beta blocker and mineralocorticoid antagonists.<unk>  is a third-line therapy. Abortion<unk>  is also used intrafetally or amniotically during abortions in the late second trimester and third trimester of pregnancy. It typically causes fetal demise (measured by cessation of cardiac activity) within hours of administration.
Digoxin
Digitoxin
Amiodarone
Metoprolol
Carvedilol
Sotalol
Bisoprolol
Captopril